Overexpression of human TRX1 in transgenic mice (TRX1-Tg) has been reported to provide a protective activity against oxidative stress-related disorders such as post-ischaemic reperfusion injury in the brain [27] kidney [28], diabetic nephropathy [29] and adriamycin-induced cardiotoxicity [30]. This evidence concerns the gene TXN and diabetic kidney disease.